ClinicalTrials.gg
RecruitingNCT07417358SSTUpdated Feb 18, 2026

Single-Stapled Technique for Colorectal Anastomosis

An observational study in Colorectal Cancer, Colorectal Anastomosis and Anastomotic Leakage, sponsored by Umeå University. Recruiting at 5 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Umeå University · Observational

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 124 studies in Colorectal Neoplasms with a site in Sweden — 27 open to participants now, 38 under way, 10 of them phase 3. Colorectal Neoplasms · Sweden.

Planned enrollment
12th of 33
500 · median 242
Started
2026
with 7 others
Observational
33 of 124
9 open now
Primary completion
2028-06
later than 25 of 37 live
Registered
120th of 124
by date

Among the 124 studies in Colorectal Neoplasms with a site in Sweden, this one is the 12th largest by planned enrollment of the 33 observational ones that give a count, is one of 8 that started in 2026, is one of 33 observational ones, reaches primary completion later than 25 of the 37 other live ones, and was the 120th registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

27 of the 124 studies in Colorectal Neoplasms with a site in Sweden are open now. Recruiting first, the newest first:

21 more — sign in →

All 27 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 124 studies in Colorectal Neoplasms with a site in Sweden, or all of them as a file.
02

Study summary

The goal of this observational multicenter study is to evaluate the safety and feasibility of a single-stapled technique (SST) for colorectal anastomosis and to explore whether this technique is associated with a reduced rate of anastomotic leakage compared with the conventional double-stapled technique (DST).

The study includes adult patients undergoing planned left-sided colorectal resection with colorectal anastomosis, including sigmoid resection, left hemicolectomy, or partial mesorectal excision (PME), for benign or malignant disease.

The main questions it aims to answer are:

What is the rate of anastomotic leakage within 90 days after surgery in patients operated with the single-stapled technique?

Is the single-stapled technique feasible and safe across different surgical approaches (open, laparoscopic, and robot-assisted surgery) in a multicenter setting?

Furthermore, outcomes after single-stapled anastomosis will be compared with a retrospective cohort of patients operated with the conventional double-stapled technique to explore potential differences in anastomotic leakage rates and postoperative complications.

Participants will receive standard surgical care as determined by the treating surgical team. Patients included in the prospective part of the study will undergo colorectal anastomosis using the single-stapled technique as part of routine clinical practice. Data on perioperative variables, postoperative complications (including anastomotic leakage graded according to international consensus definitions), and follow-up outcomes will be collected prospectively using an electronic case report form (eCRF). A retrospective cohort from the same participating centers will be identified through medical record review using identical inclusion criteria.

The results of this study are intended to provide robust multicenter data on the safety and clinical outcomes of the single-stapled technique and to serve as the basis for planning a future randomized controlled multicenter trial.

03

Conditions studied

  • Colorectal Cancer
  • Colorectal Anastomosis
  • Anastomotic Leakage
  • Diverticular Disease of Left Side of Colon

Keywords

  • Single-stapled anastomosis
  • Colorectal anastomosis
  • Anastomotic leakage
  • Colorectal surgery
  • Left-sided colon resection
  • Partial mesorectal excision
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult patients (≥18 years) undergoing planned left-sided colorectal resection with construction of a colorectal anastomosis, including left hemicolectomy, sigmoid resection, or partial mesorectal excision, for benign or malignant indications.

Patients are treated as part of routine clinical care at participating centers. The study includes both a retrospective cohort of patients operated during 2023-2025 and a prospective cohort of consecutively included patients undergoing surgery after study initiation. In the prospective cohort, the intent is to perform a single-stapled colorectal anastomosis when technically feasible in all consenting patients.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years.
  • Planned (elective) left-sided colorectal resection with creation of a colorectal anastomosis, including: Left hemicolectomy, and/or Sigmoid resection, and/or Partial mesorectal excision (PME).
  • Benign or malignant indication.
  • Prospective cohort: Ability to provide written .
  • Retrospective cohort: Eligible patients operated during 2023-2025 at participating centers, identified through medical record review, meeting the same surgical inclusion criteria.

Exclusion criteria

Exclusion Criteria:

  • Total mesorectal excision (TME) (e.g., low rectal cancer surgery requiring TME).
  • Non-left-sided colorectal resections (e.g., right-sided colectomy) or procedures outside the study-defined operations.
  • Surgery not involving a colorectal anastomosis (e.g., end colostomy/Hartmann's procedure without anastomosis).
  • Emergency/urgent colorectal resection (non-elective surgery).
  • Prospective cohort: Inability to provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Prospective single-stapled technique cohort

    Adult patients undergoing planned left-sided colorectal resection with colorectal anastomosis (including sigmoid resection, left hemicolectomy, or partial mesorectal excision) in whom the anastomosis is constructed using the single-stapled technique (SST) as part of routine clinical practice. Patients are included prospectively and followed for postoperative complications, including anastomotic leakage within 90 days, as well as longer-term outcomes.

    Procedure: Single-stapled colorectal anastomosis

  • Retrospective double-stapled technique cohort

    A retrospective cohort of adult patients who previously underwent planned left-sided colorectal resection with colorectal anastomosis using the conventional double-stapled technique (DST) during the years 2023-2025. Patients are identified through medical record review at participating centers using the same inclusion criteria as the prospective cohort, and outcome data are collected retrospectively for comparison.

    Procedure: Double-stapled colorectal anastomosis

Interventions

  • ProcedureSingle-stapled colorectal anastomosis

    Construction of a colorectal anastomosis using a single-stapled technique, where the rectal staple line is excised and a purse-string suture is placed on the rectal stump and tied around the tip of a circular stapler, before completion of the anastomosis. The procedure is performed as part of routine clinical practice during planned left-sided colorectal resection.

  • ProcedureDouble-stapled colorectal anastomosis

    Construction of a colorectal anastomosis using the conventional double-stapled technique, where the rectal stump is closed with a linear stapler and the anastomosis is completed using a circular stapler and without excision of the rectal staple line. The procedure is performed as part of standard surgical practice.

06

What researchers measure

Primary outcomes

  1. Anastomotic leakage (ISREC), within 90 days

    Anastomotic leakage following colorectal anastomosis, defined according to the International Study Group of Rectal Cancer (ISREC). Anastomotic leakage is recorded as a binary outcome (yes/no). Severity grading (ISREC Grade A, B, or C) will be reported descriptively as part of the same outcome.

    Time frame: Within 90 days after surgery

Secondary outcomes

  1. Feasibility of the single-stapled technique (SST)

    Feasibility defined as the proportion of intended SST cases in which the colorectal anastomosis could be completed using the single-stapled technique as planned, without intraoperative conversion to another anastomotic technique.

    Time frame: During surgery

  2. Completeness of stapled anastomotic rings

    Binary intraoperative assessment of stapled anastomotic ring completeness, recorded as complete or incomplete.

    Time frame: During surgery

  3. Intraoperative air leak test result

    Binary intraoperative air leak test result, recorded as leak detected or no leak detected.

    Time frame: During surgery

  4. Duration of surgery

    Total operative time measured in minutes from skin incision to skin closure.

    Time frame: During surgery

  5. Length of postoperative hospital stay

    Length of hospital stay measured in days from the date of surgery to the date of discharge.

    Time frame: Within 90 days of primary surgery

  6. Hospital readmission rate

    Proportion of patients readmitted to hospital within 90 days after surgery, with causes recorded descriptively.

    Time frame: Within 90 days after surgery

  7. Postoperative complications (Clavien-Dindo classification)

    Highest Clavien-Dindo grade within 90 days after surgery (Grade I-V), where higher grade indicates more severe complications.

    Time frame: Within 90 days after surgery

  8. All-cause mortality

    Proportion of patients who die from any cause within 90 days after surgery.

    Time frame: Within 90 days after surgery

  9. Recurrence-free survival

    Recurrence-free survival defined as time from surgery to the first occurrence of local recurrence, distant recurrence, or death from any cause.

    Time frame: Upto three years after primary surgery

  10. Stoma-free survival

    Stoma-free survival defined as survival without a diverting or permanent stoma following left-sided colorectal surgery.

    Time frame: At one and three years after surgery

07

Study locations

5 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jun 2028, 29 months after the start.

Of 531 non-industry observational studies under Colorectal Neoplasms, half reached primary completion within 56 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 132. This study's planned 29 months is below that.

Counting every sponsor, half of 648 studies reached it within 52 months; a quarter within 27 and three quarters within 104.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2026
First posted
Feb 18, 2026
StartActual
Jan 7, 2026
Primary completionEst.
Jun 30, 2028
CompletionEst.
Jun 30, 2029
Last update
Feb 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07417358
Lead sponsor
Umeå University
Collaborators
Sahlgrenska University Hospital, Skane University Hospital
Responsible party
Oskar Grahn (MD, PhD, Umeå University) — Principal investigator
First posted
Feb 18, 2026
Start date
Jan 7, 2026
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2029 (estimated)
Last update
Feb 18, 2026

Study contacts

Oskar Grahn, MD, PhD
Contact
oskar.grahn@umu.se
+46907850000
Oskar Grahn, MD, PhD
principal investigator · Umea University / Region Vasterbotten
Martin Rutegård, MD, PhD
principal investigator · Ostra Sahlgrenska University Hospital, Gothenburg, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion